Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 391, Issue 11, pp 1247–1255 | Cite as

Perindopril regulates the inflammatory mediators, NF-κB/TNF-α/IL-6, and apoptosis in cisplatin-induced renal dysfunction

  • Abdel-Gawad S. ShalkamiEmail author
  • Mohamed I. A. Hassan
  • Ahmed A. Abd El-Ghany
Original Article


Cisplatin (CP) is an essential chemotherapeutic drug used over the world against many types of cancer. It has several side effects such as ototoxicity, myelosuppression, and nephrotoxicity. Nephrotoxicity is the most dangerous and is considered a dose-limiting one. Oxidative stress, inflammation, and apoptosis are involved in this toxicity. This study was conducted to focus on the impact of perindopril (PER) against CP-induced nephrotoxicity in rat. Male albino rats were divided to control, rats received a single dose of CP, rats received PER, and rats co-received PER and CP. Nephrotoxicity evoked by CP challenge was characterized histologically and biochemically including significant increase in relative kidney/body weight ratio and serum urea and creatinine. Additionally, CP markedly increased renal tissue content of malondialdehyde (MDA) while decreased reduced glutathione (GSH) and depleted glutathione-S-transferase (GST) activity. CP produced significant increase in the inflammation biomarkers; nuclear factor-κB (NF-κB), tumor necrosis factor-α (TNF-α), and interlukine-6 (IL-6). Administration of CP clearly upregulated caspase-3, while it downregulated B-cell lymphoma-2 (BCL-2) gene expressions. Perindopril treatment showed a significant restoration in the pathological alterations histologically and biochemically, which are provoked by CP administration. Altogether, these results suggested a good therapeutic role of PER against CP-induced nephrotoxicity through its influence on oxidative stress, inflammation, and apoptosis pathway.


Cisplatin Perindopril Nephrotoxicity Inflammation Apoptosis 



The authors are grateful to Prof. Dr. Dr. Kawkab A. Ahmed, Professor of Pathology, Faculty of Veterinary Medicine, Cairo University, Egypt, for her kind help in performing the histopathological examination.

Authors’ contribution

AS Shalkami and MIA Hassan conceived and designed this research. All the authors conducted experiments. AS Shalkami and AA Abd El-Ghany analyzed data. AS Shalkami and MIA Hassan wrote the manuscript. All the authors read and approved the manuscript.

Compliance with ethical standards

All animals’ procedures in this work were conducted according to the Animal Ethics Committee, Faculty of Medicine, Assiut University, Egypt.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Banchroft JD, Stevens A, Turner DR (1996) Theory and practice of histological techniques, 4th edn. Churchill Livingstone, New YorkGoogle Scholar
  2. Baradaran A, Tavafi M, Ardalan MR et al (2016) Cisplatin; nephrotoxicity and beyond. Ann Res Antioxidants 1:e014Google Scholar
  3. Bartels H, Böhmer M, Heierli C (1972) Serum creatinine determination without protein precipitation. Clin Chim Acta 37:193–197. CrossRefPubMedGoogle Scholar
  4. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372–377. CrossRefPubMedGoogle Scholar
  5. Benigni A, Cassis P, Remuzzi G (2010) Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2:247–257. CrossRefPubMedPubMedCentralGoogle Scholar
  6. Darwish MA, Abo-Youssef AM, Khalaf MM, Abo-Saif AA, Saleh IG, Abdelghany TM (2017) Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation. J Biochem Mol Toxicol 31:1–9. CrossRefPubMedGoogle Scholar
  7. De Mello WC (2017) Local renin angiotensin aldosterone systems and cardiovascular diseases. Med Clin 101:117–127. CrossRefGoogle Scholar
  8. Dehghani A, Saberi S, Nematbakhsh M (2016) Cisplatin-induced nephrotoxicity alters blood pressure response to angiotensin II administration in rats. Adv Biomed Res 5:53. CrossRefPubMedPubMedCentralGoogle Scholar
  9. dos Santos NAG, Rodrigues MAC, Martins NM et al (2012) Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol 86:1233–1250. CrossRefPubMedGoogle Scholar
  10. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77. CrossRefPubMedGoogle Scholar
  11. Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Pathol 13:156–159CrossRefGoogle Scholar
  12. Gálvez AS, Fiedler JL, Ocaranza MP et al (2005) Perindopril regulates β-agonist-induced cardiac apoptosis. J Cardiovasc Pharmacol 46:255–261CrossRefGoogle Scholar
  13. Gross JL, De Azevedo MJ, Silveiro SP et al (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176. CrossRefPubMedGoogle Scholar
  14. Guada M, Ganugula R, Vadhanam M, Ravi Kumar MNV (2017) Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model. J Pharmacol Exp Ther 363:58–65. CrossRefPubMedGoogle Scholar
  15. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139PubMedGoogle Scholar
  16. Hayati F, Hossainzadeh M, Shayanpour S et al (2016) Prevention of cisplatin nephrotoxicity. J Nephropharmacology 5:57Google Scholar
  17. Khan MAH, Sattar MA, Abdullah NA et al (2007) Cisplatin-induced nephrotoxicity causes altered renal hemodynamics in Wistar Kyoto and spontaneously hypertensive rats: role of augmented renal alpha-adrenergic responsiveness. Exp Toxicol Pathol 59:253–260. CrossRefGoogle Scholar
  18. Lee J, Nakagiri T, Oto T, Harada M, Morii E, Shintani Y, Inoue M, Iwakura Y, Miyoshi S, Okumura M, Hirano T, Murakami M (2012) IL-6 amplifier, NF-κB–triggered positive feedback for IL-6 signaling, in grafts is involved in allogeneic rejection responses. J Immunol 189:1928–1936. CrossRefPubMedGoogle Scholar
  19. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  20. Mazia D, Brewer PA, Alfert M (1953) The cytochemical staining and measurement of protein with mercuric bromphenol blue. BiolBull 104:57–67CrossRefGoogle Scholar
  21. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2:2490–2518. CrossRefGoogle Scholar
  22. Ognjanović BI, Djordjević NZ, Matić MM, Obradović JM, Mladenović JM, Štajn AŠ, Saičić ZS (2012) Lipid peroxidative damage on cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Int J Mol Sci 13:1790–1803. CrossRefPubMedPubMedCentralGoogle Scholar
  23. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358. CrossRefPubMedGoogle Scholar
  24. Olafiranye O, Zizi F, Brimah P, Jean-louis G, Makaryus AN, McFarlane S, Ogedegbe G (2011) Management of hypertension among patients with coronary heart disease. Int J Hypertens 2011:1–6. CrossRefGoogle Scholar
  25. Peres LAB, Cunha Júnior AD (2013) Acute nephrotoxicity of cisplatin: molecular mechanisms. JBras Nefrol 35:332–340. CrossRefGoogle Scholar
  26. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT (2011) Anti-apoptosis and cell survival: a review. Biochim Biophys Acta (BBA)-Molecular Cell Res 1813:238–259. CrossRefGoogle Scholar
  27. Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G, Egido J (2005) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21:16–20. CrossRefPubMedGoogle Scholar
  28. Rüster C, Wolf G (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985–2991. CrossRefPubMedGoogle Scholar
  29. Sachse A, Wolf G (2007) Angiotensin II–induced reactive oxygen species and the kidney. J Am Soc Nephrol 18:2439–2446. CrossRefPubMedGoogle Scholar
  30. Sánchez-González PD, López-Hernández FJ, López-Novoa JM, Morales AI (2011) An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol 41:803–821. CrossRefPubMedGoogle Scholar
  31. Silici S, Ekmekcioglu O, Kanbur M, Deniz K (2011) The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats. World J Urol 29:127–132. CrossRefPubMedGoogle Scholar
  32. Slomka T, Lennon ES, Akbar H, Gosmanova EO, Bhattacharya SK, Oliphant CS, Khouzam RN (2016) Effects of renin-angiotensin-aldosterone system blockade in patients with end-stage renal disease. Am J Med Sci 351:309–316. CrossRefPubMedGoogle Scholar
  33. Strange RC, Jones PW, Fryer AA (2000) Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 112:357–363. CrossRefPubMedGoogle Scholar
  34. Sun HL, Sun L, Li YY, Shao M, Cheng X, Ge N, Lu J, Li S (2009) ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats. Exp Clin Endocrinol Diabetes 117:336–344. CrossRefPubMedGoogle Scholar
  35. Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Invest 107:7–11. CrossRefPubMedPubMedCentralGoogle Scholar
  36. Tang SCW, Leung JCK, Chan LYY, Eddy AA, Lai KN (2008) Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy. Kidney Int 73:288–299. CrossRefPubMedGoogle Scholar
  37. Topcu-Tarladacalisir Y, Sapmaz-Metin M, Karaca T (2016) Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis. Ren Fail 38:1741–1748. CrossRefPubMedGoogle Scholar
  38. Yang Y, Liu H, Liu F (2014) Mitochondrial dysregulation and protection in cisplatin nephrotoxicity. Arch Toxicol 88:1249–1256. CrossRefPubMedPubMedCentralGoogle Scholar
  39. Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115–124. CrossRefPubMedGoogle Scholar
  40. Yoshiji H, Kuriyama S, Kawata M et al (2001) The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 7:1073–1078PubMedGoogle Scholar
  41. Zhang H, Sun SC (2015) NF-κB in inflammation and renal diseases. Cell Biosci 5:63. CrossRefPubMedPubMedCentralGoogle Scholar
  42. Zhu S, Pabla N, Tang C, He L, Dong Z (2015) DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol 89:2197–2205. CrossRefPubMedPubMedCentralGoogle Scholar
  43. Zhu X, Jiang X, Li A, Zhao Z, Li S (2017) S-Allylmercaptocysteine attenuates cisplatin-induced nephrotoxicity through suppression of apoptosis, oxidative stress, and inflammation. Nutrients 9:166. CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Abdel-Gawad S. Shalkami
    • 1
    Email author
  • Mohamed I. A. Hassan
    • 1
  • Ahmed A. Abd El-Ghany
    • 2
  1. 1.Department of Pharmacology and Toxicology, Faculty of PharmacyAl-Azhar UniversityAssiutEgypt
  2. 2.Department of Biochemistry, Faculty of PharmacyAl-Azhar UniversityAssiutEgypt

Personalised recommendations